Current view of treatment of hypoglycemia

Vnitr Lek. 2019 Spring;65(4):295-299.

Abstract

Hypoglycemia is a side effect of the therapy primarily with insulin, sulphonylurea derivates and glinides. Its therapy is based on the immediate ingestion of sacharides, preferably glucose. Amount of 15-20 g is recommended as its optimal dose, although several recent studies are suggesting amount related to the patient´s weight. The therapy of severe hypoglycemia in the non-professional settings is based on glucagon injection, in the professional ones intravenous administration of glucose is preferable option.

Keywords: glucagon; glucose; hypoglycemia; therapy; type 1 diabetes; type 2 diabetes.

MeSH terms

  • Blood Glucose
  • Diabetes Mellitus, Type 1* / drug therapy
  • Glucagon
  • Humans
  • Hypoglycemia* / drug therapy
  • Hypoglycemic Agents* / adverse effects
  • Hypoglycemic Agents* / therapeutic use
  • Insulin* / adverse effects
  • Insulin* / therapeutic use

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
  • Glucagon